摘要
目的探讨垂体后叶素在新生儿心肺复苏中的应用价值。方法收集我院2007年至2011年急诊科、NICU收治的73例心跳呼吸骤停新生儿的临床资料。经常规新生儿复苏流程“ABC”急救后未复苏成功的新生儿分为肾上腺素组47例（对照组）及垂体后叶素联合肾上腺素组26例（治疗组）。结果治疗组患儿的初步复苏成功率（23．1％，6／26）与对照组（34．O％，16／47）比较差异无统计学意义（x。=0．956，P〉0．05）。结论在新生儿复苏中垂体后叶素联合肾上腺素与单独使用肾上腺素的疗效相似。
Objective To investigate the value of Pituitrin in neonatal cardiopulmonary resuscita- tion. Methods Seventy-three cases with neonatal cardiopulmonary arrest admitted in emergency department and NICU in our hospital were collected during 2007 to 2011. Newborns who did not respond to conventional neonatal resuscitation therapy were divided into two groups：epinephrine group 47 cases （control group） and Pituitrin combined with epinephrine group 26 cases （treatment group）. Results There were no statistical difference （ X2 = 0. 956 ,P 〉 0. 05 ） between treatment group and control group in the rates of initial resuscita- tion success （23. 1% ,6/26 vs 34. 0%, 16/47）. Conclusion Pituitrin combined with epinephrine has similar efficacy with the use of epinephrine in neonatal cardiopulmonary resuscitation.
出处
《中国小儿急救医学》
CAS
2014年第3期137-139,共3页
Chinese Pediatric Emergency Medicine
基金
江西省科技攻关计划资助项目（2006）
关键词
肾上腺素
垂体后叶素
心肺复苏
新生儿
Epinephrine
Pituitrin
Cardiopulmonary resuscitation
Newborn
